stockportfolio.pro
TransMedics Group, Inc. Revenue 2018–2025
TransMedics Group, Inc. (TMDX) annual revenue by fiscal year, computed from SEC filings. Compound growth +73.1%/yr over 7 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $605.49M | +37.1% |
| FY 2024 | $441.54M | +82.7% |
| FY 2023 | $241.62M | +158.5% |
| FY 2022 | $93.46M | +208.8% |
| FY 2021 | $30.26M | +18.0% |
| FY 2020 | $25.64M | +8.6% |
| FY 2019 | $23.60M | +81.3% |
| FY 2018 | $13.02M | — |
Source: TransMedics Group, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for TransMedics Group, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTransMedics Group, Inc. — frequently asked questions
What is TransMedics Group, Inc.'s revenue?
TransMedics Group, Inc. (TMDX) reported revenue of $605.49M for fiscal year 2025, per its SEC filings.
How has TransMedics Group, Inc.'s revenue changed over time?
Between fiscal 2018 and 2025, TMDX's revenue grew at roughly 73.1% per year (compound annual rate), from $13.02M to $605.49M.
Where does this data come from?
Figures are computed from TransMedics Group, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.